Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.055 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |